Gyre Therapeutics GYRE
NASDAQ GYRE
$4.26 +0.03 (+0.71%)
At close: Nov 11, 2026 · 4:00 PM EST

Gyre Therapeutics (GYRE) Return on Assets [ROA] (2009 - 2026)

Updated

Gyre Therapeutics' Return on Assets [ROA] was -10.83% in Q2 2026, down 14.31 percentage points from 3.49% a year earlier and down 6.89 percentage points from the prior quarter.

Analysis

Gyre Therapeutics (GYRE) Return on Assets [ROA] (2009 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Gyre Therapeutics came in at 5.72%, down 9.07 percentage points from FY2024.

  • Return on Assets [ROA] shows a five-year change of +63.89 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was 14.80% in FY2024 (+99.73 pp), -84.93% in FY2023 (-91.08 pp), 6.14% in FY2022 (+122.99 pp) and -116.85% in FY2021 (-58.69 pp).
  • The Q2 2026 figure marks the lowest quarterly Return on Assets [ROA] since Q3 2024.
  • Compared with a year earlier, Return on Assets [ROA] has declined for three straight quarters, with an average year-over-year change of +46.44 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q1 2023 (a gain of 211.42 percentage points); the worst was Q2 2023 (a drop of 145.53 percentage points).
  • Per Business Quant data, GYRE's Return on Assets [ROA] in the three quarters before Q2 2026 was -3.94% (Q1 2026), 3.20% (Q4 2025) and 5.13% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Gyre Therapeutics 487.81 Mn 295.13 Mn 30.99 Mn -10.66%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -10.66%
Jun 30, 2026 -9.38%
Mar 31, 2026 -2.58%
Dec 31, 2025 4.58%
Sep 30, 2025 2.56%
Jun 30, 2025 3.49%
Mar 31, 2025 9.17%
Dec 31, 2024 14.28%
Sep 30, 2024 -67.96%
Jun 30, 2024 -65.03%
Mar 31, 2024 -66.87%
Dec 31, 2023 -135.14%
Sep 30, 2023 -110.93%
Jun 30, 2023 -159.23%
Mar 31, 2023 44.57%
Dec 31, 2022 7.45%
Sep 30, 2022 20.78%
Jun 30, 2022 -13.70%
Mar 31, 2022 -166.84%
Dec 31, 2021 -131.05%
API Access

Gyre Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GYRE&period=max&api_key=YOUR_API_KEY